BOT or NOT? This special series explores the evolving relationship between humans and machines, examining the ways that robots, artificial intelligence and automation are impacting our work and lives.
Design what’s next. From targeted drug delivery to climate-resilient plants, the power to shape the future relies on the ability to design and evaluate at the molecular level. Our interdisciplinary ...
Proteins are social creatures. They’re also chameleons. Depending on a cell’s needs, they rapidly transform in structure and grab onto other biomolecules in an intricate dance. It’s not molecular ...
New artificial intelligence tools for biomolecular design enable researchers to build completely new proteins. The past month has seen the release of code from at least two new tools for making ...
The College of Science, Institute of Physical AI, Purdue Institute of Inflammation, Immunology and Infectious Disease, Purdue Institute for Cancer Research, Bindley Bioscience Center and Rosen Center ...
The partnership brings together Pfizer’s scientific data and therapeutic expertise with Boltz’s open-source AI foundation ...
Framework for nanoscale material design using programmable DNA systems enables precise control over structure, function, and immune signaling in soft materials. (Nanowerk Spotlight) Nucleic acids ...
CAMBRIDGE, Mass., Jan. 8, 2026 /PRNewswire/ -- Pfizer Inc. and Boltz, PBC, an applied AI research lab, today announced a ...
Computational drug discovery and design integrates advanced computer‐aided methodologies with chemical and biological insights to accelerate the identification and optimisation of therapeutic agents.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback